ALB and hepatocellular carcinoma: Similar to SVR24, WFA±M2BP ≥ 1.85 COI (HR: 35.3, 95% CI: 4.25–293, p < 0.001), albumin, platelet counts, and presence of LR3/4 nodules (HR: 60.1, 95%CI: 13.2–273, p < 0.001) at 1 year after SVR24 were associated with HCC development in the univariate analysis.